Consistently, double knockdown of FGFR4 and EZH2 exerted stronger inhibitory effects on HCC cell proliferation than single knockdown of FGFR4 or EZH2 (Fig. S4M). The gene discussed is EZH2; the disease is hepatocellular carcinoma.